MedTrace Logo

National Covid-19 Surveillance Physicians

NCT04459312 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2020-07-08

No results posted yet for this study

Summary

The investigators will analyze the presence of antibodies against SARS-COV2 in physicians working in emergency and intensive care medicine and in those who treat Covid 19 patients.

Conditions

  • Antibody COVID-19

Interventions

DIAGNOSTIC_TEST

Antibody test (SARS-CoV2)

Antibody test

Sponsors & Collaborators

  • Dr. Wetzchewald

    collaborator UNKNOWN

  • Heinrich-Heine University, Duesseldorf

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2020-07-10
Completion
2020-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04459312 on ClinicalTrials.gov